Restarting Apixaban After Surgery

Timing and Hemostasis

The European Society of Cardiology guidelines recommend restarting apixaban as soon as adequate hemostasis is achieved, which can be as early as 6 hours after low bleeding risk procedures, but should be delayed 24-72 hours after high bleeding risk surgeries 1, 2, 3
For procedures with immediate and complete hemostasis, resumption can occur 6-8 hours post-intervention, according to the European Heart Journal 3
Delay resumption for 24-48 hours (or up to 48-72 hours) until hemostasis is secure, as recommended by the European Heart Journal and Praxis Medical Insights 1, 2, 3

Never restart apixaban if there is ongoing bleeding or surgical contraindication, as stated by Praxis Medical Insights 1
Confirm adequate hemostasis before resuming therapy, according to Praxis Medical Insights 1
If unexpected heavy bleeding occurs, delay resumption until bleeding is controlled, as recommended by Praxis Medical Insights 1

Do not use bridging anticoagulation with heparin when restarting apixaban, as stated by Praxis Medical Insights 1, 2
For procedures associated with immobilization, consider reduced venous thromboprophylactic or intermediate-dose LMWH 6-8 hours after surgery if hemostasis is achieved, while deferring full therapeutic anticoagulation with apixaban for 48-72 hours, according to the European Heart Journal 3
Bridging increases bleeding risk without reducing thrombotic risk, as noted by Praxis Medical Insights 1, 2

Patients over 80 years may require more conservative timing due to increased bleeding risk, as recommended by Praxis Medical Insights 2
Ensure complete hemostasis before resumption in elderly patients, according to Praxis Medical Insights 2
Consider slightly longer delays in resumption for patients with significant renal dysfunction, as noted by Praxis Medical Insights 2